Chemistry – A European Journal, ISSN 0947-6539, 11/2018, Volume 24, Issue 66, pp. 17367 - 17367
The synthesis of phenanthroline‐containing polymer chains enables the subsequent incorporation of metal‐ions to generate functional macromolecular...
copolymerization | N ligands | nanoparticles | supramolecular chemistry | lanthanides
copolymerization | N ligands | nanoparticles | supramolecular chemistry | lanthanides
Journal Article
Molecular Microbiology, ISSN 0950-382X, 08/2016, Volume 101, Issue 4, pp. 559 - 574
Journal Article
Nucleic acids research, ISSN 0305-1048, 2014, Volume 42, Issue 15, pp. 9717 - 9729
Base J, beta-d-glucosyl-hydroxymethyluracil, is an epigenetic modification of thymine in the nuclear DNA of flagellated protozoa of the order Kinetoplastida. J...
VARIANT SURFACE GLYCOPROTEIN | RNA-POLYMERASE-II | DNA GLYCOSYLATION | MESSENGER-RNA | HELA-CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | SWI2/SNF2-LIKE PROTEIN | GENE-EXPRESSION | 5-BROMODEOXYURIDINE | POLYCISTRONIC TRANSCRIPTION | GENOME | Cell Line | Leishmania major - enzymology | Leishmania major - genetics | Transcription Termination, Genetic | Gene Expression Regulation | RNA Polymerase II - metabolism | Trypanosoma brucei brucei - genetics | Uracil - physiology | Trypanosoma brucei brucei - enzymology | RNA, Protozoan - analysis | Glucosides | Uracil - analogs & derivatives | Gene regulation, Chromatin and Epigenetics
VARIANT SURFACE GLYCOPROTEIN | RNA-POLYMERASE-II | DNA GLYCOSYLATION | MESSENGER-RNA | HELA-CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | SWI2/SNF2-LIKE PROTEIN | GENE-EXPRESSION | 5-BROMODEOXYURIDINE | POLYCISTRONIC TRANSCRIPTION | GENOME | Cell Line | Leishmania major - enzymology | Leishmania major - genetics | Transcription Termination, Genetic | Gene Expression Regulation | RNA Polymerase II - metabolism | Trypanosoma brucei brucei - genetics | Uracil - physiology | Trypanosoma brucei brucei - enzymology | RNA, Protozoan - analysis | Glucosides | Uracil - analogs & derivatives | Gene regulation, Chromatin and Epigenetics
Journal Article
Journal of Algebra, ISSN 0021-8693, 11/2017, Volume 489, p. 586
The following note contains corrections to our 2009 publication .
Algebra
Algebra
Journal Article
Molecular Microbiology, ISSN 0950-382X, 08/2016, Volume 101, Issue 4, pp. 559 - 574
Summary The genomes of kinetoplastids are organized into polycistronic gene clusters that are flanked by the modified DNA base J. Previous work has established...
TRYPANOSOMA-BRUCEI | CRUZI | MESSENGER-RNA | HYDROXYMETHYLURACIL | DNA | BIOCHEMISTRY & MOLECULAR BIOLOGY | MICROBIOLOGY | GLUCOSYLTRANSFERASE | TRANSCRIPTION INITIATION | PARASITE | EXPRESSION | GENOME | Multigene Family | Leishmania major - genetics | RNA, Messenger - genetics | Gene Expression Regulation | RNA Polymerase II - metabolism | RNA, Messenger - metabolism | Glucosides - metabolism | Glucosides - genetics | Leishmania major - enzymology | Leishmania major - metabolism | RNA Polymerase II - genetics | Uracil - metabolism | Transcription, Genetic - genetics | Uracil - analogs & derivatives | Genetic transcription | RNA | Genes | RNA polymerases | Gene expression | Bacteriology | RNA polymerase
TRYPANOSOMA-BRUCEI | CRUZI | MESSENGER-RNA | HYDROXYMETHYLURACIL | DNA | BIOCHEMISTRY & MOLECULAR BIOLOGY | MICROBIOLOGY | GLUCOSYLTRANSFERASE | TRANSCRIPTION INITIATION | PARASITE | EXPRESSION | GENOME | Multigene Family | Leishmania major - genetics | RNA, Messenger - genetics | Gene Expression Regulation | RNA Polymerase II - metabolism | RNA, Messenger - metabolism | Glucosides - metabolism | Glucosides - genetics | Leishmania major - enzymology | Leishmania major - metabolism | RNA Polymerase II - genetics | Uracil - metabolism | Transcription, Genetic - genetics | Uracil - analogs & derivatives | Genetic transcription | RNA | Genes | RNA polymerases | Gene expression | Bacteriology | RNA polymerase
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The...
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article